1. Home
  2. HPK vs NTLA Comparison

HPK vs NTLA Comparison

Compare HPK & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HPK
  • NTLA
  • Stock Information
  • Founded
  • HPK 2019
  • NTLA 2014
  • Country
  • HPK United States
  • NTLA United States
  • Employees
  • HPK N/A
  • NTLA N/A
  • Industry
  • HPK Oil & Gas Production
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • HPK Energy
  • NTLA Health Care
  • Exchange
  • HPK Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • HPK 1.6B
  • NTLA 1.4B
  • IPO Year
  • HPK N/A
  • NTLA 2016
  • Fundamental
  • Price
  • HPK $14.02
  • NTLA $12.18
  • Analyst Decision
  • HPK Hold
  • NTLA Buy
  • Analyst Count
  • HPK 1
  • NTLA 17
  • Target Price
  • HPK $14.00
  • NTLA $56.63
  • AVG Volume (30 Days)
  • HPK 275.5K
  • NTLA 2.4M
  • Earning Date
  • HPK 11-04-2024
  • NTLA 02-20-2025
  • Dividend Yield
  • HPK 1.14%
  • NTLA N/A
  • EPS Growth
  • HPK N/A
  • NTLA N/A
  • EPS
  • HPK 1.26
  • NTLA N/A
  • Revenue
  • HPK $1,135,761,000.00
  • NTLA $43,086,000.00
  • Revenue This Year
  • HPK N/A
  • NTLA $52.50
  • Revenue Next Year
  • HPK N/A
  • NTLA $0.42
  • P/E Ratio
  • HPK $11.15
  • NTLA N/A
  • Revenue Growth
  • HPK 6.34
  • NTLA N/A
  • 52 Week Low
  • HPK $12.47
  • NTLA $11.79
  • 52 Week High
  • HPK $17.48
  • NTLA $34.87
  • Technical
  • Relative Strength Index (RSI)
  • HPK 43.84
  • NTLA 34.42
  • Support Level
  • HPK $13.70
  • NTLA $11.79
  • Resistance Level
  • HPK $14.76
  • NTLA $13.79
  • Average True Range (ATR)
  • HPK 0.49
  • NTLA 0.85
  • MACD
  • HPK -0.09
  • NTLA -0.14
  • Stochastic Oscillator
  • HPK 16.77
  • NTLA 9.97

About HPK HighPeak Energy Inc.

HighPeak Energy Inc is an independent oil and natural gas company focused on the development of unconventional oil and natural gas reserves in Howard County of the Midland Basin. The company operates in a single segment, which is oil and natural gas development, exploration, and production.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: